title: [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
abstract: In carcinoid syndrome, calcitonin administration proved to have an effective action in reducing symptomatology. During the perioperative period, treatment with somatostatin, thanks to the ease of administration of the drug and the reductive action of gastroenteric secretion, demonstrated its usefulness in countering the action of serotonin. In the present case, the data reported in the most recent literature on the use of the two drugs in the carcinoid syndrome are confirmed.
authors.forename: V
authors.initials: V
authors.lastname: Festa
authors.forename: C
authors.initials: C
authors.lastname: Garrone
authors.forename: G
authors.initials: G
authors.lastname: Vietti Ramus
authors.forename: F
authors.initials: F
authors.lastname: Lisa
authors.forename: P
authors.initials: P
authors.lastname: Simone
authors.forename: M
authors.initials: M
authors.lastname: Scotti
authors.forename: D
authors.initials: D
authors.lastname: Cocchis
authors.forename: G C
authors.initials: GC
authors.lastname: Garrone
mesh_terms: D000368:Aged; D002116:Calcitonin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D013004:Somatostatin / Q000627:therapeutic use*
chemical_list: C056877:calcitonin, salmon, Arg(11,18)-Lys(14)-; D013004:Somatostatin; D002116:Calcitonin
vernacular_title: Effetto della somatostatina e della calcitonina di salmone nella sindrome da carcinoide. Caso clinico.